Complementary and Alternative Medicine Use in Chronic Liver Disease Patients

Leah M. Ferrucci, Beth P. Bell, Kathy B. Dhotre, M. Michele Manos, Norah A. Terrault, Atif Zaman, Rosemary C. Murphy, Grace R. VanNess, Ann R. Thomas, Stephanie R. Bialek, Mayur M. Desai, Andre N. Sofair

Research output: Contribution to journalArticle

37 Scopus citations

Abstract

To examine a wide range of sociodemographic and clinical characteristics as potential predictors of complementary and alternative medicine (CAM) use among chronic liver disease (CLD) patients, with a focus on CAM therapies with the greatest potential for hepatotoxicity and interactions with conventional treatments. There is some evidence that patients with CLD commonly use CAM to address general and CLD-specific health concerns.

Original languageEnglish (US)
Pages (from-to)e40-e45
JournalJournal of Clinical Gastroenterology
Volume44
Issue number2
DOIs
StatePublished - Feb 2010

Keywords

  • Chronic liver disease
  • Complementary and alternative medicine
  • Epidemiology

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Complementary and Alternative Medicine Use in Chronic Liver Disease Patients'. Together they form a unique fingerprint.

  • Cite this

    Ferrucci, L. M., Bell, B. P., Dhotre, K. B., Manos, M. M., Terrault, N. A., Zaman, A., Murphy, R. C., VanNess, G. R., Thomas, A. R., Bialek, S. R., Desai, M. M., & Sofair, A. N. (2010). Complementary and Alternative Medicine Use in Chronic Liver Disease Patients. Journal of Clinical Gastroenterology, 44(2), e40-e45. https://doi.org/10.1097/MCG.0b013e3181b766ed